| |
 |
|
|
Science Forum Index » Medicine - Cancer Forum » Recent review articles about lung cancer...
Page 1 of 1
|
| Author |
Message |
| ... |
 Posted: Sat Aug 02, 2008 8:28 am |
|
|
|
Guest
|
Recent review articles about lung cancer:
Benign tumors and tumorlike conditions of the lung.
Borczuk AC.
Arch Pathol Lab Med. 2008 Jul;132(7):1133-48.
Avoiding underdiagnosis, overdiagnosis, and misdiagnosis of lung
carcinoma.
Butnor KJ.
Arch Pathol Lab Med. 2008 Jul;132(7):1118-32.
Pulmonary sarcomatous tumors.
Litzky LA.
Arch Pathol Lab Med. 2008 Jul;132(7):1104-17.
Pulmonary preneoplasia.
Dacic S.
Arch Pathol Lab Med. 2008 Jul;132(7):1073-8.
Lung tumors with neuroendocrine morphology: essential radiologic and
pathologic features.
Franks TJ, Galvin JR.
Arch Pathol Lab Med. 2008 Jul;132(7):1055-61.
Is our natural-history model of lung cancer wrong?
Bach PB.
Lancet Oncol. 2008 Jul;9(7):693-7.
Poor usage of HUGO standard gene nomenclature in cancer marker
studies.
Lacroix M.
Int J Biol Markers. 2008 April - June;23(2):123-126.
Molecular genetics of lung cancer in people who have never smoked.
Subramanian J, Govindan R.
Lancet Oncol. 2008 Jul;9(7):676-82.
Second-hand smoke and human lung cancer.
Besaratinia A, Pfeifer GP.
Lancet Oncol. 2008 Jul;9(7):657-66.
Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond.
Ladanyi M, Pao W.
Mod Pathol. 2008 May;21 Suppl 2:S16-22.
The future of cancer vaccines for non-small-cell lung cancer: ongoing
trials.
Choudhury A, Palma M, Mellstedt H.
Clin Lung Cancer. 2008 Feb;9 Suppl 1:S37-44.
Cancer stem cells and the ontogeny of lung cancer.
Peacock CD, Watkins DN.
J Clin Oncol. 2008 Jun 10;26(17):2883-9.
First-line chemotherapy in metastatic colorectal cancer: new
approaches and therapeutic algorithms. Always hit hard first?
Loupakis F, Masi G, Vasile E, Falcone A.
Curr Opin Oncol. 2008 Jul;20(4):459-65.
Cooperative group portfolio in locally advanced non-small-cell lung
cancer: are we making progress?
Langer CJ, Wakelee H, Schiller J, Choy H, Shepherd F, Vokes EE, Adjei
AA, Baas P, Saijo N, Gandara DR.
Clin Lung Cancer. 2008 Mar;9(2):85-91.
Advances in genomic and proteomic studies of non-small-cell lung
cancer: clinical and translational research perspective.
Dziadziuszko R, Hirsch FR.
Clin Lung Cancer. 2008 Mar;9(2):78-84.
LKB1 and lung cancer: more than the usual suspects.
Shah U, Sharpless NE, Hayes DN.
Cancer Res. 2008 May 15;68(10):3562-5.
Current status of clinical trials for small cell lung cancer.
Fischer B, Arcaro A.
Rev Recent Clin Trials. 2008 Jan;3(1):40-61.
Vascular endothelial growth factor receptor tyrosine kinase inhibitors
in non-small cell lung cancer: a review of recent clinical trials.
Lee CB, Socinski MA.
Rev Recent Clin Trials. 2007 May;2(2):117-20.
Bcl-2-targeted antisense therapy (Oblimersen sodium): towards clinical
reality.
Moreira JN, Santos A, Simões S.
Rev Recent Clin Trials. 2006 Sep;1(3):217-35.
Does an optimal therapeutic sequence exist in advanced non-small cell
lung cancer?
Gebbia V.
Expert Opin Pharmacother. 2008 Jun;9( :1321-37.
Bronchopulmonary neuroendocrine tumors.
Gustafsson BI, Kidd M, Chan A, Malfertheiner MV, Modlin IM.
Cancer. 2008 Jul 1;113(1):5-21.
Bevacizumab for the treatment of advanced non-small-cell lung cancer.
Manegold C.
Expert Rev Anticancer Ther. 2008 May;8(5):689-99.
Targeting growth factors in lung cancer.
Hodkinson PS, Mackinnon A, Sethi T.
Chest. 2008 May;133(5):1209-16.
(contact at InTextoResearch: Marc Lacroix, Baelen, Wallonia, Belgium -
scimedweb at (no spam) mail.com) |
|
|
| Back to top |
|
| |
|
Page 1 of 1
All times are GMT - 5 Hours
The time now is Thu Jan 08, 2009 1:29 pm
|
|